Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Matthew L. Holzner, Parissa Tabrizian, Fatemeh P. Parvin‐Nejad, Kezhen Fei, Ganesh Gunasekaran, Chiara Rocha, Marcelo E. Facciuto, Sander Florman, Myron E. Schwartz – 30 April 2020 – Mixed hepatocellular‐cholangiocarcinoma (HCC‐CC) is a biphenotypic liver cancer thought to have unfavorable tumor biology and a poor prognosis. Surgical outcomes of HCC‐CC remain unclear. We aimed to evaluate the clinical characteristics and surgical outcomes of HCC‐CC.

Hepatology Highlights

Joseph F. Pisa, Robert S. Brown, Petra Hirsova, Robert E. Schwartz, Tejasav S. Sehrawat, Nicholas W. Russo, Enis Kostallari, Zaid H. Tafesh, Brett Fortune, Hirsh D. Trivedi, Daryl T.Y. Lau, Angel Morales‐Santiago, Joel Wedd, Samuel C. Buchl, Jessica L. Maiers – 29 April 2020

Subscribe to